Cargando…
Development of Edaravone Ionic Liquids and Their Application for the Treatment of Cerebral Ischemia/Reperfusion Injury
[Image: see text] Preparation of the ionic liquid (IL) form of active pharmaceutical ingredients (APIs), termed API-IL, has attracted attention because it can improve upon certain disadvantages of APIs, such as poor water solubility and low stability. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one)...
Autores principales: | Fukuta, Tatsuya, Ikeda-Imafuku, Mayumi, Iwao, Yasunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245372/ https://www.ncbi.nlm.nih.gov/pubmed/37155370 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00103 |
Ejemplares similares
-
Metabolomic Profiling of Brain Protective Effect of Edaravone on Cerebral Ischemia-Reperfusion Injury in Mice
por: Ma, Hui-fen, et al.
Publicado: (2022) -
One-Step Pharmaceutical Preparation of PEG-Modified Exosomes Encapsulating Anti-Cancer Drugs by a High-Pressure Homogenization Technique
por: Fukuta, Tatsuya, et al.
Publicado: (2023) -
Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO‐1 signaling pathway in mice
por: Xu, Lili, et al.
Publicado: (2022) -
Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb
por: Hori, Kazuichiro, et al.
Publicado: (2013) -
Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
por: Deguchi, Kentaro, et al.
Publicado: (2014)